* Orgenesis Inc ORGS.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in June. The lone
analyst forecast for the quarter was for earnings of 6 cents per
share.
* Revenue fell 3.1% to $6.98 million from a year ago;
analysts
expected $10.70 million.
* Orgenesis Inc's reported EPS for the quarter was a loss
of 15
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Orgenesis Inc shares had fallen by 29.1% this quarter and
lost 49.4% so far this year.
* The company reported a quarterly loss of $4.13 million.
* Wall Street's median 12-month price target for Orgenesis
Inc is
$6.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 11 at 12:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 0.06 -0.15 Missed
Mar. 31 2023 0.05 -0.17 Missed
Dec. 31 2022 0.00 -0.16 Missed
Sep. 30 2022 -0.02 -0.05 Missed